The TB Vaccine Advocacy Roadmap (TB Vax ARM) released a policy brief elaborating on the urgent need of developing new TB vaccines to tackle antimicrobial resistance (AMR). Developing new TB vaccines by 2030 is within reach if decision-makers prioritize TB vaccine research and development as a signature piece of global health and AMR agendas.
“Vaccines that prevent TB disease would save millions of lives, avert billions of dollars in treatment costs, and help curb the threat of AMR.”
Access the policy brief here.
The TB Vaccine Advocacy Roadmap (TB Vax ARM) represents a global coalition of TB stakeholders, including TB survivors, civil society organizations, and non-profits, invested in TB vaccine advocacy and research.
For more TB updates, check out the latest edition of the TB Online Weekly Newsletter (#20, 30 June 2024).
The TB Online Weekly Newsletter is brought to you by TB CAB and EATG. Subscribe to the newsletter here.
Source : TB Online
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.